Published in Am J Physiol Gastrointest Liver Physiol on May 11, 2006
Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers. Aliment Pharmacol Ther (2015) 3.35
Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest (2007) 2.28
Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol (2010) 1.38
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig Dis Sci (2011) 1.21
Novel therapies for coeliac disease. J Intern Med (2011) 1.17
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
A food-grade enzyme preparation with modest gluten detoxification properties. PLoS One (2009) 1.10
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol (2007) 1.04
Oral enzyme therapy for celiac sprue. Methods Enzymol (2012) 1.03
Celiac disease: quantity matters. Semin Immunopathol (2012) 1.03
Recent advances in celiac disease. World J Gastroenterol (2011) 1.03
Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. PLoS One (2010) 1.00
Oral proteases: a new approach to managing coeliac disease. Gut (2006) 0.97
Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. PLoS One (2011) 0.96
The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity. Clin Microbiol Infect (2013) 0.95
Noninflammatory gluten peptide analogs as biomarkers for celiac sprue. Chem Biol (2009) 0.91
Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog (2008) 0.91
Celiac disease: advances in treatment via gluten modification. Clin Gastroenterol Hepatol (2012) 0.90
Mechanism of degradation of immunogenic gluten epitopes from Triticum turgidum L. var. durum by sourdough lactobacilli and fungal proteases. Appl Environ Microbiol (2009) 0.89
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Computational design of an α-gliadin peptidase. J Am Chem Soc (2012) 0.86
Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements. PLoS One (2015) 0.85
Gene cloning and enzymatic characterization of an endoprotease Endo-Pro-Aspergillus niger. J Ind Microbiol Biotechnol (2013) 0.81
Identification of gliadin-binding peptides by phage display. BMC Biotechnol (2011) 0.81
Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol (2015) 0.81
Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease. Am J Gastroenterol (2015) 0.80
Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut (2009) 0.80
Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol (2010) 0.79
Latest in vitro and in vivo models of celiac disease. Expert Opin Drug Discov (2013) 0.79
New and developing therapies for celiac disease. Therap Adv Gastroenterol (2009) 0.79
Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms. Gut Liver (2015) 0.79
The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques. Nutrients (2015) 0.79
Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy. Viszeralmedizin (2014) 0.79
Non-dietary forms of treatment for adult celiac disease. World J Gastrointest Pharmacol Ther (2013) 0.78
Current and emerging therapy for celiac disease. Front Med (Lausanne) (2014) 0.78
Transcriptome analysis of a barley breeding program examines gene expression diversity and reveals target genes for malting quality improvement. BMC Genomics (2010) 0.77
Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol (2014) 0.77
Quantitation of the immunodominant 33-mer peptide from α-gliadin in wheat flours by liquid chromatography tandem mass spectrometry. Sci Rep (2017) 0.75
Microbial Proteases in Baked Goods: Modification of Gluten and Effects on Immunogenicity and Product Quality. Foods (2016) 0.75
Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Sci Rep (2016) 0.75
Sourdough-Based Biotechnologies for the Production of Gluten-Free Foods. Foods (2016) 0.75
Personalizing Protein Nourishment. Crit Rev Food Sci Nutr (2015) 0.75
Elevated CD8 T cell responses in type 1 diabetes patients to a 13 amino acid coeliac-active peptide from α-gliadin. Clin Exp Immunol (2014) 0.75
Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
The Aspergillus niger Prolyl endoprotease (An-PEP) for hydrogen-deuterium exchange mass spectrometry and protein structural studies. Anal Chem (2017) 0.75
Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting. Sci Rep (2017) 0.75
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med (2006) 4.84
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut (2010) 3.09
The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology (2002) 2.91
Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology (2005) 2.66
Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med (2002) 2.49
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci U S A (2003) 2.30
Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology (2003) 2.23
The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J Mol Biol (2005) 2.04
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity (2003) 1.89
Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics (2012) 1.79
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics (2006) 1.70
Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut (2012) 1.52
Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition (2008) 1.45
Celiac disease--sandwiched between innate and adaptive immunity. Hum Immunol (2006) 1.44
The molecular basis for oat intolerance in patients with celiac disease. PLoS Med (2004) 1.40
Celiac disease: how complicated can it get? Immunogenetics (2010) 1.34
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol (2010) 1.24
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood (2003) 1.18
Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med (2006) 1.17
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes (2013) 1.16
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells. Diabetes (2012) 1.15
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol (2013) 1.14
Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol (2004) 1.13
A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med (2003) 1.10
Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J Immunol (2008) 1.08
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med (2009) 1.05
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz. Proc Natl Acad Sci U S A (2010) 1.04
A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One (2010) 1.02
Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity (2012) 1.01
Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit beta5t. Chem Biol (2010) 1.01
Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J Immunol (2004) 1.01
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol (2009) 0.97
T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics (2005) 0.96
HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J Immunol (2002) 0.96
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology (2011) 0.96
Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis (Edinb) (2007) 0.96
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer. J Immunol (2011) 0.95
Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem (2011) 0.94
Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 0.91
Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation. BMC Genomics (2012) 0.91
Functional killer Ig-like receptors on human memory CD4+ T cells specific for cytomegalovirus. J Immunol (2009) 0.91
Direct induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins. Mol Nutr Food Res (2010) 0.91
Effective prevention of chill-haze in beer using an acid proline-specific endoprotease from Aspergillus niger. J Agric Food Chem (2005) 0.90
The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol (2010) 0.90
Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol (2012) 0.90
On-line high-performance liquid chromatography/mass spectrometric characterization of native oligosaccharides from glycoproteins. Rapid Commun Mass Spectrom (2002) 0.90
Validation of a new enzyme-linked immunosorbent assay to detect the triggering proteins and peptides for celiac disease: interlaboratory study. J AOAC Int (2012) 0.89
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
The Ethiopian cereal tef in celiac disease. N Engl J Med (2005) 0.88
Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics. Inflamm Bowel Dis (2011) 0.88
The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology (2010) 0.87
Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol (2004) 0.86
Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome. Am J Clin Nutr (2008) 0.86
Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. Am J Pathol (2007) 0.84
Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol (2009) 0.84
No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population. Am J Physiol Gastrointest Liver Physiol (2005) 0.84
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol (2005) 0.83
CD8 T-cell recognition of human 5T4 oncofetal antigen. Int J Cancer (2006) 0.83
Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. J Clin Endocrinol Metab (2008) 0.83
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Invest Ophthalmol Vis Sci (2009) 0.82
Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule. Immunogenetics (2008) 0.82
The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6J mice. Diabetologia (2015) 0.82
Enzymatic gluten detoxification: the proof of the pudding is in the eating! Trends Biotechnol (2006) 0.82
Gluten peptides and celiac disease. Science (2003) 0.82
Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? Eur J Gastroenterol Hepatol (2008) 0.81
Cutting edge: killer Ig-like receptors mediate "missing self" recognition in vivo. J Immunol (2009) 0.81
Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms. J Bacteriol (2005) 0.81
Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol Immunol (2009) 0.80
Development of an activity-based probe for autotaxin. Chembiochem (2010) 0.80
Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation. Int Immunol (2007) 0.80
Tef in the diet of celiac patients in The Netherlands. Scand J Gastroenterol (2008) 0.80
A novel specific pyrosequencing method for genotyping FCGR3A rs396991 without coamplification of homologous gene FCGR3B. Pharmacogenet Genomics (2013) 0.79
Tissue transglutaminase: master regulator of celiac disease? J Pediatr Gastroenterol Nutr (2003) 0.79
Therapy in RCDII: Rationale for Combination Strategies? Dig Dis (2015) 0.78
Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease. Bioorg Med Chem (2007) 0.78
HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. J Immunol (2013) 0.78
Design of new high-affinity peptide ligands for human leukocyte antigen-DQ2 using a positional scanning peptide library. Hum Immunol (2010) 0.77
The million-dollar question: is "gluten-free" food safe for patients with celiac disease? Am J Clin Nutr (2012) 0.77
DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients. J Immunol (2011) 0.77
Successful treatment of coeliac disease by allogeneic haematopoietic stem cell transplantation. J Pediatr Gastroenterol Nutr (2010) 0.76
Anticytomegalovirus seropositivity in rheumatoid arthritis is not associated with the presence of severe extraarticular complications: comment on the article by Pierer et al. Arthritis Rheum (2012) 0.75
Unique peptide-binding motif for Mamu-B*037:01: an MHC class I allele common to Indian and Chinese rhesus macaques. Immunogenetics (2013) 0.75
Pathophysiology of celiac disease. J Pediatr Gastroenterol Nutr (2014) 0.75